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We examined the protective effect of Brazilian propolis against liver damage with cholestasis in rats treated with 𝛼-
naphthylisothiocyanate (ANIT) in comparison with that of vitamin E (VE). Rats orally received Brazilian propolis ethanol extract
(BPEE) (25, 50, or 100mg/kg), VE (250mg/kg) or vehicle at 12 h after intraperitoneal injection of ANIT (75mg/kg) and were
killed 24 h after the injection. Vehicle-treated rats showed liver cell damage and cholestasis, judging from the levels of serum
marker enzymes and components. The vehicle group had increased serum total cholesterol, triglyceride, phospholipid, and lipid
peroxide levels, increased hepatic lipid peroxide, reduced glutathione, and ascorbic acid levels and myeloperoxidase activity, and
decreased hepatic superoxide dismutase activity. BPEE (50mg/kg) administered to ANIT-treated rats prevented liver cell damage
and cholestasis and attenuated these serum and hepatic biochemical changes except hepatic ascorbic acid, although administered
BPEE (25 or 100mg/kg)was less effective. VE administered toANIT-treated rats prevented liver cell damage, but not cholestasis, and
attenuated increased serum lipid peroxide level, increased hepatic lipid peroxide level and myeloperoxidase activity, and decreased
hepatic superoxide dismutase activity.These results indicate that BPEEprotects against ANIT-induced liver damagewith cholestasis
in rats more effectively than VE.
1. Introduction
Propolis (bee glue) is a resinous hive product collected by
honeybee from various plant sources. Propolis has important
pharmacological properties, and it can be used for a wide
range of purposes as antiinflammatory, antioxidant, antibac-
terial, antiulcerous, and antitumor agents [1, 2]. Chemically,
propolis obtained from different areas of the world is con-
stituted by 50%–60% of resin, 30%–40% of wax, 5%–10%
of essential oils, and 5% of pollen, besides microelements
[3]. Propolis contains various organic compounds such as
phenols, tannins, polysaccharides, terpenes, aromatic acids,
and aldehydes [1, 3–6].
Propolis collected from different areas of the world has
been reported to exert a protective effect against in vivo
acute liver damage in rats treated with hepatotoxicants such
as carbon tetrachloride [7–12], D-galactosamine [13, 14],
acetaminophen [15, 16], and econazole [17] through its several
pharmacological actions to suppress hepatic oxidative stress
associated with lipid peroxidation [7–11, 13, 16, 17] to inhibit
hepatic drug-metabolizing enzymes [11, 12, 14, 15] and to
ameliorate hyperlipemia [7, 12]. However, it is still unknown
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whether propolis exerts a protective effect against in vivo
acute liver damage with cholestasis in rats.
A single treatment of experimental animals with 𝛼-
naphthylisothiocyanate (ANIT) is known to induce liver
damage with intrahepatic cholestasis [18–20]. This ANIT-
induced liver damage with cholestasis is thought to be useful
for studying the mechanisms of drug-induced cholestasis,
because liver damage and cholestasis resulting from the
administration of certain drugs (e.g., erythromycin estolate,
chlorpromazine, and others) to humans are mimicked by
ANIT administration to rats [20].Themechanisms of ANIT-
induced liver damage with cholestasis have been proposed
but have not been entirely clarified yet. It has been suggested
that hepatic reduced glutathione (GSH) contributes to the
development of ANIT-induced liver damage with cholestasis
by virtue of its ability to form a reversible S-conjugate of
ANIT that is critical in shuttling ANIT into bile, where it
is released in large and probably toxic concentrations [21].
It has also been suggested that inflammation mediated by
infiltrated neutrophils contributes to the development of
ANIT-induced liver damage with cholestasis in rats [21].
Furthermore, it has been shown in rats treated once with
ANIT that lipid peroxidation induced by reactive oxygen
species (ROS) generated via infiltrated neutrophils in the
liver tissue is involved in the development of liver damage
with cholestasis [22]. It has also been shown in ANIT-
treated rats that disruption of hepatic antioxidant defense
system contributes to the development of liver damage with
cholestasis [23, 24].
The ethanol extract of Brazilian propolis is known to
possess antioxidant and anti-inflammatory properties [25–
31]. Vitamin E (VE) is well known to exert antioxidant and
anti-inflammatory actions [32–35]. Our resent report has
shown that the ethanol extract of Brazilian propolis protects
against stress-induced liver damage in rats, at least in part,
through its antioxidant and anti-inflammatory actions as in
the case of VE [36]. Furthermore, it has been shown that VE
protects against liver cell damage, but not cholestasis, in rats
with a single ANIT treatment, at least in part, through its
antioxidant and anti-inflammatory actions [37].
We, therefore, examined the protective effect of the
ethanol extract of Brazilian green propolis against ANIT-
induced liver damage with cholestasis in rats in comparison
with that of VE.
2. Materials and Methods
2.1. Materials. ANIT, bovine serum albumin, 3,3󸀠,5,5󸀠-te-
tramethylbenzidine (TMB), p-coumaric acid, RRR-𝛼-
tocopherol (𝛼-Toc) used for VE administration, superoxide
dismutase (SOD) purified from bovine erythrocytes, and
yeast glutathione reductase were purchased from Sigma
(St. Louis, MO, USA); NADPH from Oriental Yeast Co.
(Tokyo, Japan); chlorogenic acid from Tokyo Chemical
Ind., Co. Ltd. (Tokyo, Japan); artepillin C, L-ascorbic acid,
cinnamic acid, chrysin, N,N-dimethylformamide, 𝛼,𝛼’-
dipyridyl, 5,5󸀠-dithiobis(2-nitrobenzoic acid) (DTNB),
ethylenediaminetetraacetic acid (EDTA), Folin-Ciocalteu
reagent, gallic acid, kaempferol, quercetin, reduced glu-
tathione (GSH), 2-thiobarbituric acid, trichloroacetic acid
(TCA), standard 𝛼-Toc and 𝛿-tocopherol used for VE
determination, Tween 80, and other chemicals from Wako
Pure Chemical Ind., Ltd. (Osaka, Japan). All chemicals used
were of reagent grade and were not further purified.
2.2. Preparation of the Ethanol Extract of Brazilian Propolis.
Brazilian green propolis was collected in the area of Minas
Gerais in Brazil byMNPropolis Ind., Come´rcio e Exportace¯o,
Ltda (Mogi das Cruzes, SP, Brazil). The collected propolis
(Lot no. KA-02) was provided by Japan Beekeeping Co.
Ltd. (Gifu, Japan). The quality of the provided propolis had
been certificated as follows: artepillin C, 10.1%; flavonoids,
41.1mg/g; and bee wax, 5.6%. Ethanol extraction of Brazilian
green propolis was conducted as follows: approximately 35 g
of crude propolis was added to 100mL of 95% ethanol and the
mixture was kept at room temperature for 7 days. The final
concentration of ethanol in the Brazilian propolis ethanol
extract (BPEE) prepared was 80%. When the prepared BPEE
was completely dried at 40∘C, the content of solid compo-
nents was estimated to be 13.2%. The content of flavonoids
in BPEE was determined according to the method of Dowd
[38].
2.3. Chemical Composition Analysis. The content of total
flavonoid in BPEE is expressed as that of quercetin equiva-
lents. The content of polyphenols in BPEE was determined
by the Folin-Ciocalteau colorimetricmethod described in the
report of Ahn et al. [39]. The content of total polyphenol
in BPEE is expressed as that of gallic acid equivalents.
The main constituents in BPEE were analyzed by HPLC
according to the method described by Izuta et al. [27] except
that the mobile phase consisting of 1% acetic acid in 55%
methanol was replaced by the mobile phase consisting of
1% acetic acid in 69% methanol. The HPLC was performed
on a reversed-phase Shim-Pack CLC-ODS (15 cm × 4.5mm
i.d., Shimadzu, Kyoto, Japan) column with water-methanol-
acetic acid (30 : 70 : 1, v/v) as a mobile phase at a flow
rate of 1mL/min at 40∘C. The volume of the BPEE sample
injected to the columnwas 5 𝜇L.The detection of chlorogenic
acid, p-coumaric acid, quercetin, cinnamic acid, kaempherol,
chrysin, and artepllin C in BPEE was conducted at 290 nm
and the content of each constituent was estimated using its
authentic compound.
2.4. Experimental Animals. Male Wistar rats aged six weeks
were purchased from Nippon SLC Co. (Hamamatsu, Japan).
The animals were housed in cages in a ventilated animal room
with controlled temperature (23± 2∘C) and relative humidity
(55 ± 5%) with 12 h of light (7:00 to 19:00). The animals
were maintained with free access to rat chow, Oriental MF
(Oriental Yeast Co., Tokyo, Japan) and tap water for one
week. All animals received humane care in compliance with
the Guidelines of the Management of Laboratory Animals
in Fujita Health University. This animal experiment protocol
was approved by the Institutional Animal Care and Use
Committee.
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2.5. Experimental Groups andAdministrations of ANIT, BPEE,
and VE. Rats were divided into 6 groups as follows: Con-
trol group: rats not given ANIT and either BPEE or VE
(𝑛 = 5), ANIT group: rats treated with ANIT alone (𝑛 =
7), ANIT + BPEE(25) group: rats treated with ANIT and
postadministered with BPEE at a dose of 25mg/kg (𝑛 =
7), ANIT + BPEE(50) group: rats treated with ANIT and
postadministered with BPEE at a dose of 50mg/kg (𝑛 =
7), ANIT + BPEE(100) group: rats treated with ANIT and
postadministered with BPEE at a dose of 100mg/kg (𝑛 =
7), and ANIT + VE group: rats treated with ANIT and
postadministered with VE (𝑛 = 7). ANIT treatment and
postadministration of BPEEorVEwere conducted as follows:
ANIT was dissolved in olive oil. BPEE was diluted with
5% Tween 80 solution and the diluted BPEE contained 6%
ethanol. Therefore, VE (RRR-𝛼-Toc) was dissolved in 5%
Tween 80 containing 6% ethanol (Tween 80-EtOH). In all
groups with ANIT treatment, seven-week-old rats fasted for
15 h received an intraperitoneal (i.p.) injection of ANIT at a
dose of 75mg per kg body weight, that is, 1mL of the ANIT
solution (7.5mg/mL) per 100 g body weight, as described
previously [22–24, 37]. Age-matched rats fasted for 15 h in the
control group received an i.p. injection of the same volume of
olive oil used as vehicle. At 12 h after the initial i.p. injection
of ANIT or vehicle (olive oil), rats in the groups with ANIT
treatment were orally administered with BPEE at a dose of
25, 50, or 100mg of solid components present in the extract
per kg BW or the prepared VE at a dose of 250mg per kg
bodyweight. Namely, ANIT-treated rats received a single oral
administration of 1mL of the diluted BPEE solution, the VE
solution, or vehicle (Tween 80-EtOH) per 100 g body weight.
The dose of VE used in the present study was determined
based on the data shown in our previous report [37]. OnemL
of Tween 80-EtOH used as vehicle per 100 g body weight was
orally administered to rats in Control group at the same time
point. All rats used were fasted and received water ad libitum
during experiments.
2.6. Sample Preparation. At 24 h after the initial ANIT
or vehicle injection, each rat was weighed and then was
sacrificed under ether anesthesia at which time blood was
collected from the inferior vena cava. Serum was separated
from the collected blood by centrifugation. Immediately after
sacrifice, each liver was perfused with ice-cold 0.9% NaCl to
remove blood remaining in the tissue and then weighed after
washing in an ice-cold 0.9% NaCl solution and wiping on
a paper filter. The collected livers and serum were stored at
−80∘C until use.
2.7. Assays of Serum Components and Enzymes. Serum ala-
nine aminotransferase (ALT) and aspartate aminotransferase
(AST) were assayed using a commercial kit of Transaminase
II-Test Wako. Serum 𝛾-glutamyl transpeptidase (𝛾-GTP) was
assayed using a commercial kit of 𝛾-GTP C-Test Wako.
These enzyme activities are expressed as an international unit
(IU/l). Serum total bilirubin and total bile acid were assayed
using commercial kits of Bilirubin BII-Test Wako and Total
bile acid-Test Wako, respectively. Total cholesterol (T-Chol),
triglyceride, and phospholipid in serum were assayed using
commercial kits of Cholesterol E-Test Wako, Triglyceride
G-Test Wako, and Phospholipid C-Test Wako, respectively.
These kits were obtained from Wako Pure Chemical Ind.
Ltd. Co., Osaka, Japan. Lipid peroxide (LPO) in serum was
fluorometrically measured by the thiobarbituric acid method
of Yagi [40] using tetramethoxypropane as a standard. In this
assay, the excitation and emission wavelengths were 515 and
553 nm, respectively. The amount of serum LPO is expressed
as that of malondialdehyde (MDA) equivalents.
2.8. Assays of Hepatic Components and Enzymes. The
weight of each isolated liver was estimated using its relative
weight (g/100 g body weight). The isolated liver tissue was
homogenized in 9 volumes of ice-cold 50mM Tris-HCl
buffer (pH 7.4) containing 1mM EDTA to prepare 10%
homogenate using a Physcotron handy microhomogenizer
(Microtec Co., Funabashi, Japan). The liver homogenate
was used for the assays of GSH, 𝛼-Toc, ascorbic acid, and
LPO. GSH in the liver homogenate was assayed by the
DTNB method of Sedlak and Lindsay [41] using GSH as
a standard. 𝛼-Toc in the liver homogenate was assayed by
the HPLC method with electrochemical detection using
𝛿-tocopherol as an internal standard as described in our
previous report [42]. Ascorbic acid in the liver homogenate
was assayed by the 𝛼,𝛼’-dipyridyl method of Zannoni et al.
[43]. The concentration of ascorbic acid was assayed using
the standard curve of authentic L-ascorbic acid. LPO in
the liver homogenate was spectrophotometrically assayed
by the thiobarbituric acid method of Ohkawa et al. [44]
using tetramethoxypropane as a standard except that 1mM
EDTA was added to the reaction mixtures. The amount of
hepatic LPO is expressed as that ofMDA equivalents. Hepatic
SOD was assayed using a commercial kit of SOD Assay Kit-
WST (Doindo, Kumamoto, Japan). Hepatic catalase and Se-
glutathione peroxidase (Se-GSH-px) were assayed according
to the methods of Bergmeyer [45] and Hochstein and Utley
[46], respectively. Hepatic myeloperoxidase (MPO), an index
of tissue neutrophil infiltration [47], was assayed by the
method of Suzuki et al. [48]. For the assays of these enzymes,
the isolated liver tissue was homogenized in 9 volumes of
ice-cold 0.05M Tris-HCl buffer (pH 7.4) using a Physcotron
handy microhomogenizer. After sonication on ice for 20 sec
using a Handy Sonic model UR-20P, the homogenate was
centrifuged at 4∘C (10,000×g, 20min), and the resultant
supernatant was dialyzed against 100 volumes of the same
buffer at 4∘C for 1 h using a microdialysis device (molecular
weight cutoff 3,500, Bio-Tec International Inc., Belleuve, WA,
USA). SOD activity in the dialyzed liver tissue supernatant
was determined at 37∘C using purified erythrocyte SOD
(5,000 units/mg solid) as a standard.This activity is expressed
as the unit (U) of authentic purified bovine erythrocyte
SOD showing activity equivalent to the determined activity.
Catalase activity in the dialyzed liver tissue supernatant was
measured at 37∘C by recording hydrogen peroxide (H
2
O
2
)
decomposition at 240 nm in the reaction system (1.0mL)
consisting of 10mM H
2
O
2
, an appropriate amount of the
dialyzed liver supernatant, and 100mMphosphate buffer (pH
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7.0). One unit (U) of this activity is defined as the amount of
enzymedecomposing 1 𝜇molH
2
O
2
as a substrate permin. Se-
GSH-px activity in the dialyzed liver tissue supernatant was
measured at 37∘C by recording the decrease in absorbance at
340 nm following the oxidation of NADPH in the reaction
system (1.0mL) consisting of 2mM GSH, 0.2 unit of yeast
glutathione reductase, 1mMNaN
3
, as a catalase inhibitor, an
appropriate amount of the dialyzed liver supernatant, 2mM
H
2
O
2
as a substrate, and 50mM phosphate buffer (pH 7.0).
One unit (U) of this activity is defined as the amount of
enzyme oxidizing 1 𝜇mol NADPH per min. MPO activity
in the dialyzed liver tissue supernatant was determined as
follows: the dialyzed liver tissue supernatant was incubated at
60∘C for 2 h to increase the recovery of MPO in liver tissues
according to the method of Schierwagen et al. [49]. MPO
activity in the heated liver tissue sample was assessed bymea-
suring the hydrogen peroxide-dependent oxidation of TMB
at 37∘C. TMBwas dissolved inN,N-dimethylformamide. One
unit (U) of this enzyme is defined as the amount of enzyme
causing a change in absorbance of 1.0 per min at 655 nm.
Protein in the dialyzed liver tissue supernatant was measured
using Protein Assay Rapid kit (Wako Pure Chemical Ind. Ltd.
Co, Osaka, Japan). The amount of protein in the liver tissue
supernatant is expressed as that of bovine serum albumin
used as a standard.
2.9. Histological Examination. Liver sampleswere taken from
the central part of the right larger lobe of ANIT-treated
rats with either BPEE or VE administration and untreated
control rats at 24 h after ANIT treatment. They were fixed
with 10% formalin in phosphate buffered saline for 24 h and
then washed with tap water, dehydrated in alcohols, and
embedded in paraffin. Sections 6-7𝜇mthickweremounted in
glass slides. Staining with hematoxylin and eosin (H-E) was
performed in each slide and then histological examination
was conducted under light microscopy.
2.10. Statistical Analysis. All results obtained are expressed as
means ± standard deviation (S.D.). The statistical analyses of
the results were performed using a computerized statistical
package (StatView). Each mean value was compared by one-
way analysis of variance (ANOVA) and Bonferroni/Dunn for
multiple comparisons. The significance level was set at 𝑃 <
0.05.
3. Results
3.1. Chemical Composition. The contents of total flavonoid
and total polyphenol in BPEE used in the present study were
21.3 and 69.0mg/g of solid propolis, respectively.The contents
of p-coumaric acid, kaempferol, chrysin, and artepillin C in
the extract were 14.9, 6.75, 2.38, and 47.8mg/g of solid propo-
lis, respectively. However, no chlorogenic acid, quercetin, and
cinnamic acid were detected in the extract.
3.2. Effects of BPEE and VE on f Liver Cell Damage and
Cholestasis. Serum ALT and AST activities, indices of liver
cell damage, and 𝛾-GTP activity and total bilirubin and
total bile acid concentrations, indices of biliary cell damage
and cholestasis, were significantly higher in ANIT group
than in Control group (Figures 1 and 2). The ANIT-induced
increases in serum ALT, AST, and 𝛾-GTP activities were
significantly attenuated in ANIT + BPEE(25), ANIT +
BPEE(50), and ANIT + BPEE(100) groups, while the ANIT-
induced increases in serum ALT and AST activities were
significantly attenuated inANIT+VEgroup (Figures 1(a) and
2(a)). The attenuating effect on the ANIT-induced increase
in serum ALT activity in ANIT + BPEE(50) group was
significantly larger than that in ANIT + BPEE(25) and ANIT
+ BPEE(100) groups, while the attenuating effect on ANIT-
induced increases in AST and 𝛾-GTP activities in ANIT +
BPEE(50) group tended to be larger than that in ANIT +
BPEE25 and ANIT + BPEE(100) groups (Figures 1(a) and
2(a)). The attenuating effect on ANIT-induced increases in
serum ALT and AST activities in ANIT + BPEE(50) group
was almost equal to that in ANIT + VE group (Figure 1).
The ANIT-induced increases in serum total bilirubin and
total bile acid concentrations were significantly attenuated in
ANIT + BPEE(50) group (Figures 2(b) and 2(c)). However,
the ANIT-induced increases in serum total bilirubin and
total bile acid concentrations were not attenuated in ANIT +
BPEE(25) group (Figures 2(b) and 2(c)). Though the ANIT-
induced increases in serum total bilirubin concentration
were significantly attenuated in ANIT + BPEE(100) group,
the attenuating effect in ANIT + BPEE(100) group was
significantly less than that in ANIT + BPEE(50) group (𝑃 <
0.05) (Figures 2(b) and 2(c)). InANIT+VE group, theANIT-
induced increases in serum total bilirubin and total bile acid
concentrations were not attenuated at all (Figures 2(b) and
2(c)).
3.3. Effects of BPEE and VE on Live Histological Changes. H-
E-stained liver sections from Control group, ANIT group,
ANIT + BPEE(50) group, and ANIT + VE group were exam-
ined for necrosis and inflammation. Control group showed
little histological changes, ANIT group presented necrotic
and degenerative changes with severe inflammatory cell
infiltration, and ANIT + BPEE(50) and ANIT + VE groups
presented clearly less necrotic and degenerative changes and
less inflammatory cell infiltration (Figure 3). In addition, the
histological change in ANIT + BPEE(50) group was similar
to that in ANIT + VE group (Figures 3(c) and 3(d)).
3.4. Effects of BPEE and VE on Serum Lipid Concentrations.
Serum T-Chol, triglyceride, and phospholipid concentra-
tions were significantly higher in ANIT group than in
Control group (Figure 4). In ANIT + BPEE50 group, the
ANIT-induced increases in serum T-Chol, triglyceride, and
phospholipid concentrations were significantly attenuated
(Figure 4). However, only the ANIT-induced increase in
serum triglyceride concentration was significantly attenuated
in ANIT + BPEE(25) group, but no significant effects on
the ANIT-induced increases in serum T-Chol, triglyceride,
and phospholipid concentrations were observed in ANIT +
BPEE(100) and ANIT + VE groups (Figure 4).
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Figure 1: Effects of administered BPEE and VE on serum ALT (a) and AST (b) activities in ANIT-treated rats. Fasted rats in ANIT, ANIT +
BPEE(25), ANIT + BPEE(50), ANIT + BPEE(100), and ANIT +VE groups were orally administered with vehicle (Tween 80-EtOH), 25mg/kg
of BPEE, 50mg/kg of BPEE, 100mg/kg of BPEE, and 250mg/kg of VE, respectively, at 12 h after treatment with ANIT dissolved in olive oil
(75mg/kg, i.p.). Fasted rats in Control group were given olive oil and Tween 80-EtOH used as vehicle just before and at 12 h after ANIT
treatment, respectively. ALT and AST in serum were assayed at 24 h after ANIT treatment as described in Section 2 . Each value is a mean ±
S.D. (𝑛 = 5 for Control group; 𝑛 = 7 per each group for all groups with ANIT treatment). ∗𝑃 < 0.05 (versus Control group); #𝑃 < 0.05 (versus
ANIT group).
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Figure 2: Effects of administered BPEE and VE on serum 𝛾-GTP (a) activity and total bilirubin (b) and total bile acid (c) concentrations
in ANIT-treated rats. Experimental condition and explanation are the same as described in the legend of Figure 1 except that 𝛾-GTP, total
bilirubin, and total bile acid in serum were assayed at 24 h after ANIT treatment as described in Section 2. Each value is a mean ± S.D. (𝑛 = 5
for Control group; 𝑛 = 7 per each group for all groups with ANIT treatment). ∗𝑃 < 0.05 (versus Control group); #𝑃 < 0.05 (versus ANIT
group).
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Control
(a)
ANIT
(b)
ANIT + BPEE (50)
(c)
ANIT + VE
(d)
Figure 3:Histological Figures of liver cells fromuntreated control rats andANIT-treated rats with andwithout either BPEE orVE. (a) Control
group: little histological change was observed; (b) ANIT group: necrotic and degenerative changes with severe inflammatory cell infiltration
were observed; (c) ANIT + BPEE50 group: dramatic decreases in necrotic and degenerative changes and inflammatory cell infiltration were
seen; (d)ANIT+VEgroup:marked decreases in necrotic anddegenerative changes and inflammatory cell infiltrationwere seen (H-E staining,
original magnification ×100).
3.5. Effects of BPEE and VE on Relative Liver Weight. ANIT
group had significantly larger relative liver weight than Con-
trol group (Figure 5). In ANIT + BPEE(50) group, the ANIT-
induced increase in relative liver weight was significantly
attenuated, while no significant effect on the increase in the
relative liver weight was observed in ANIT + BPEE(25),
ANIT + BPEE(100), and ANIT + VE groups (Figure 5).
3.6. Effects of BPEE and VE on Serum and Hepatic LPO Con-
centrations. Serum and hepatic LPO concentrations were
significantly higher in ANIT group than in Control group
(Figure 6).TheANIT-induced increases in serum and hepatic
LPO concentrations were significantly attenuated in ANIT +
BPEE(50), ANIT + BPEE(100), and ANIT + VE groups, but
no significant effect on both increases was found in ANIT
+ BPEE(25) group (Figure 6). The attenuating effects on the
increases in serum and hepatic LPO concentrations in ANIT
+BPEE(50), groupwere similar to those inANIT+VEgroup,
but were significantly larger than those in ANIT + BPEE(100)
group (𝑃 < 0.05) (Figure 6).
3.7. Effects of BPEE and VE on Hepatic Antioxidant Enzyme
Activities. Hepatic SOD activity was significantly lower in
ANIT group than in Control group, although there were
no significant differences in hepatic catalase and Se-GSH-px
activities between both groups (Figure 7).TheANIT-induced
decrease in hepatic SOD activity was significantly attenuated
in ANIT +BPEE(25), ANIT + BPEE(50), ANIT + BPEE(100),
and ANIT + VE groups, although ANIT + BPEE(50) group
showed themost effective attenuation among the three ANIT
+ BPEE groups (Figure 7(a)). In addition, the hepatic SOD
activity in ANIT + BPEE(50) or ANIT + BPEE(100) group
was not different from that in control group (Figure 7(a)).
ANIT + BPEE(25), ANIT + BPEE(50), and ANIT + VE
groups had no significant effect on hepatic catalase activity
but the enzyme activity was significantly reduced in ANIT
+ BPEE(100) group (Figure 7(b)). ANIT + BPEE(25), ANIT
+ BPEE(50) or ANIT + BPEE(100) group had no significant
effect on hepatic Se-GSH-px activity but ANIT + VE group
had a significant increase in that activity (Figure 7(c)).
3.8. Effects of BPEE and VE on Hepatic Antioxidant Con-
centrations. Hepatic GSH and ascorbic acid concentrations
were significantly higher in ANIT group than in Control
group but there was no significant difference in hepatic 𝛼-Toc
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Figure 4: Effects of administered BPEE and VE on serum T-Chol (a), triglyceride (b), and phospholipid (c) concentrations in ANIT-treated
rats. Experimental condition and explanation are the same as described in the legend of Figure 1 except that T-Chol, triglyceride, and
phospholipid in serum were assayed at 24 h after ANIT treatment as described in Section 2. Each value is a mean ± S.D. (𝑛 = 5 for Control
group; 𝑛 = 7 per each group for all groups with ANIT treatment). ∗𝑃 < 0.05 (versus Control group); #𝑃 < 0.05 (versus ANIT group).
concentration between both groups (Figure 8). The ANIT-
induced increase in hepatic GSH concentration was signif-
icantly attenuated in ANIT + BPEE(25), ANIT + BPEE(50)
or ANIT + BPEE(100) group and the attenuating effect of
BPEE occurred in a dose-dependent manner, while ANIT +
VE group had no significant effect on the increased hepatic
GSH concentration (Figure 8(a)). ANIT + BPEE(25), ANIT
+ BPEE(50), ANIT + BPEE(100), and ANIT +VE groups had
no significant effect on the ANIT-induced increase in hepatic
ascorbic acid concentration (Figure 8(b)). ANIT + BPEE(25),
ANIT + BPEE(50), and ANIT + BPEE(100) groups showed
no significant effect on the hepatic 𝛼-Toc concentration but
ANIT + VE group had a significant and marked increase in
the hepatic 𝛼-Toc concentration (Figure 8(c)).
3.9. Effects of BPEE and VE on Neutrophil Infiltration. Hep-
atic MPO activity was significantly higher in ANIT group
than inControl group (Figure 9).TheANIT-induced increase
in hepaticMPO activity was significantly attenuated in ANIT
+ BPEE(50) and ANIT + VE groups, although neither ANIT
+ BPEE(25) group nor ANIT + BPEE(100) group had any
significant effect on the increase in hepatic MPO activity
(Figure 9). The attenuating effect on the ANIT-induced
increase in hepatic MPO activity was significantly less in
ANIT + BPEE(50) group than in ANIT + VE group (𝑃 <
0.05) (Figure 9).
4. Discussion
The presence of p-coumaric acid, kaempferol, chrysin, and
artepillin C in BPEE, which was prepared by extraction of
Brazilian green propolis with 95% ethanol and used in the
present study, was confirmed by the HPLC analysis used and
the content of artepillin Cwas the highest among the contents
of four constituents determined. This result was consistent
with previous reports [5, 27, 50].
Our previous reports have shown that rats treated once
with ANIT (75mg/kg, i.p.) have liver cell damage and
cholestasis, judging from the serum levels of ALT and AST,
indices of liver cell damage, and 𝛾-GTP, total bilirubin, and
total bile acid, indices of biliary cell damage and cholestasis,
at 24 h, but not at 12 h, after the treatment [22–24, 37]. In
the present study, a single oral administration of BPEE or
VE to ANIT-treated rats was conducted at 12 h after ANIT
treatment, because this delayed administration of BPEE or
VE is thought to be useful for providing the administration
effect of the extract or the vitamin on ANIT-induced liver
damage with cholestasis in a condition closer to the clinical
situation. When liver cell damage was evaluated from the
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Figure 5: Effects of administered BPEE and VE on liver weight in
ANIT-treated rats. Experimental condition and explanation are the
same as described in the legend of Figure 1 except that the liver
weight of each rat was estimated using its relative weight (g/100 g
body weight) at 24 h after ANIT treatment as described in Section 2.
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Control group); #𝑃 < 0.05 (versus ANIT group).
changes in serumALTandAST activities, BPEE administered
at a dose of 25, 50, or 100mg/kg at 12 h after ANIT treatment
was found to protect against ANIT-induced liver cell damage
in rats. However, the protective effect of BPEE was higher
at its dose of 50mg/kg than at its dose of 25 or 100mg/kg,
indicating that the protective effect of BPEE against ANIT-
induced liver cell damage is diminished at its high dose. VE
(250mg/kg) administered to ANIT-treated rats at 12 h after
the treatment attenuated the increases in serumALT andAST
activities, as reported previously [37], and these effects were
similar to those of BPEE (50mg/kg). When the serum levels
of 𝛾-GTP, total bilirubin, and total bile acid were examined as
indices of biliary damage and cholestasis, orally administered
BPEE (25, 50, or 100mg/kg)was found to attenuate theANIT-
induced increase in serum 𝛾-GTP activity, although BPEE
at a dose of 50mg/kg was more effective than its dose of 25
or 100mg/kg. In addition, BPEE administered at a dose of
50mg/kg had a larger attenuating effect on the increases in
serum total bilirubin and total bile acid concentrations than
its dose of 25 or 100mg/kg.The administeredVEhadno effect
on the ANIT-induced increases in serum 𝛾-GTP activity and
total bilirubin and total bile acid concentrations, as reported
previously [37]. Thus, orally administered BPEE (50mg/kg)
was found to protect against ANIT-induced liver damage
with cholestasis in rats more effectively than the similarly
administered VE (250mg/kg). However, BPEE administered
at a dose of 100mg/kg was found to reduce its protective
effect against ANIT-induced liver damage with cholestasis.
Our recent report [36] has shown that a single oral pread-
ministration of BPEE (50mg/kg) to rats subjected to water-
immersion restraint stress is more effective in protecting
against liver oxidative damage induced by the stress than
that of BPEE (100mg/kg). In addition, orally administered
BPEE (50mg/kg) was found to attenuate histological changes
associated with necrosis and inflammation in liver cells
observed in rats treated with ANIT alone as in the case of
orally administered VE.
It is known that, in rats treated once with ANIT,
increases in serum or plasma free cholesterol, cholesteryl
ester, triglyceride, and phospholipid concentrations due to
serum or plasma lipoprotein abnormality occur with the
development of liver damage with cholestasis [51–53]. In the
present study, ANIT-treated rats had increased serum T-
Chol, triglyceride, and phospholipid concentrations at 24 h
after the treatment and especially the treated rats had a
marked increase in serum phospholipid concentration, as
reported previously [51–53]. A single oral administration
of BPEE (50mg/kg) caused a significant attenuation of
the ANIT-induced increases in serum T-Chol, triglyceride,
and phospholipid concentrations, although the similarly
administered BPEE (25 or 100mg/kg) was less effective. By
contrast, the similarly administered VE (250mg/kg) had no
significant effect on not only the increases in serum T-Chol
and triglyceride concentrations, as reported previously [37],
but also the increase in serum phospholipid concentration.
Thus, orally administered BPEE (50mg/kg) was found to be
effective in attenuating increased serum T-Chol, triglyceride,
and phospholipid concentrations in ANIT-treated rats. This
attenuating effect of BPEE on ANIT-induced increases in
serum lipid concentrations may be associated with ame-
lioration of serum lipoprotein abnormality, although the
attenuating mechanism is unclear at present.
It has been shown in rats treated once with ANIT
(75mg/kg, i.p.) that the relative liver weight (g/100 g body
weight) begins to increase before the appearance of liver
damage with cholestasis and further increases after the
appearance of liver damage with cholestasis [22, 54]. In
the present study, a single oral administration of BPEE
(50mg/kg) to ANIT-treated rats at 12 h after the treatment
caused a significant attenuation of the increase in relative
liver weight found at 24 h, while the similarly administered
BPEE (25 or 100mg/kg) and VE (250mg/kg) had no sig-
nificant effect on the increased relative liver weight. Thus,
orally administered BPEE (50mg/kg) was found to suppress
hepatic hypertrophy in ANIT-treated rats. However, both
the mechanism for ANIT-induced hepatic hypertrophy in
rats and the mechanism by which BPEE suppresses hepatic
hypertrophy in ANIT-treated rats are unclear at present.
The ethanol extract of Brazilian propolis is known to exert
antioxidant action by scavenging ROS and by inhibiting lipid
peroxidation [25–28]. VE is known to function as a scavenger
of ROS and as a chain breaker for lipid peroxidation [32]. It
has been shown that hepatic lipid peroxidation contributes
to the development of liver damage with cholestasis in rats
treated once with ANIT [22, 23, 37, 54]. It is known that
rats treated once with ANIT (75mg/kg, i.p.) have significant
increases in hepatic and serum LPO concentrations at 24 h
after the treatment, although a significant increase in LPO
concentration in the liver, but not in the serum, of ANIT-
treated rats occurs at 12 h after the treatment [22, 23, 37, 55].
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Figure 6: Effects of administered BPEE and VE on LPO concentrations in the serum (a) and liver (b) of ANIT-treated rats. Experimental
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Figure 7: Effects of administered BPEE and VE on hepatic SOD (a), catalase (b), and Se-GSH-px (c) activities in ANIT-treated rats.
Experimental condition and explanation are the same as described in the legend of Figure 1 except that SOD, catalase, and Se-GSH-px in
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Figure 8: Effects of administered BPEE and VE on hepatic GSH (a), ascorbic acid (b), and 𝛼-Toc (c) concentrations in ANIT-treated rats.
Experimental condition and explanation are the same as described in the legend of Figure 1 except that GSH, ascorbic acid, and 𝛼-Toc in liver
tissues were assayed at 24 h after ANIT treatment as described in Section 2. Each value is a mean ± S.D. (𝑛 = 5 for Control group; 𝑛 = 7 per
each group for all groups with ANIT treatment). ∗𝑃 < 0.05 (versus Control group); #𝑃 < 0.05 (versus ANIT group).
In the present study, a single oral administration of BPEE (50
or 100mg/kg) to ANIT-treated rats at 12 h after the treatment
caused a significant attenuation of the increased hepatic and
serum LPO concentrations found at 24 h, although BPEE
at a dose of 50mg/kg was more effective than its dose
of 100mg/kg. The similarly administered VE (250mg/kg)
caused a significant attenuation of the increased hepatic
and serum LPO concentrations found at 24 h after ANIT
treatment, as reported previously [37]. The ability of BPEE
(50mg/kg) to attenuate the ANIT-induced increases in hep-
atic and serum LPO concentrations was almost equal to that
of VE (250mg/kg). Therefore, it was suggested that BPEE
orally administered to ANIT-treated rats could suppress
lipid peroxidation occurring in the liver tissue through its
antioxidant property.
It has been shown in rats treated once with ANIT
(75mg/kg, i.p.) that the hepatic SOD activity decreases at
24 h, but not 12 h, after the treatment, while the hepatic
catalase and Se-GSH-px activities increase at 12 h, although
the increased catalase and Se-GSH-px activities are returned
to the levels of untreated control rats at 24 h [23, 24]. In the
present study, a single oral administration of BPEE (25, 50,
or 100mg/kg) to ANIT-treated at 12 h after ANIT treatment
caused a significant attenuation of the decreased hepatic SOD
activity found at 24 h but the administered BPEE (50mg/kg)
exerted the highest effect and caused a complete return of
the decreased hepatic SOD activity to the level of untreated
control rats. The administered BPEE (25 or 50mg/kg) had
no effect on the hepatic catalase activity found at 24 h after
ANIT treatment, while the administered BPEE (100mg/kg)
caused a significant reduction of the hepatic catalase activity.
All doses of BPEE had no effect on the hepatic Se-GSH-px
activity found at 24 h after ANIT treatment. By contrast, VE
(250mg/kg) administered to ANIT-treated rats did not affect
the hepatic catalase activity but caused a significant increase
in the hepatic Se-GSH-px activity, although the adminis-
tered VE partially attenuated the ANIT-induced decrease in
hepatic SOD activity. Thus, orally administered BPEE was
found to ameliorate disrupted hepatic enzymatic antioxidant
defense system associated with SOD in ANIT-treated rats.
It has been reported that rats treated once with ANIT
(75mg/kg, i.p.) have increased hepatic GSH concentration
at 24 h after the treatment, increased ascorbic acid con-
centration at 12 and 24 h, and unchanged hepatic 𝛼-Toc
concentration at 12 and 24 h [23, 24, 37]. In the present
study, a single oral administration of BPEE (25, 50, or
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100mg/kg) to ANIT-treated rats at 12 h after the treatment
caused a significant attenuation of the increased hepatic
GSH concentration found at 24 h but had no effect on the
increased hepatic ascorbic acid concentration and the hepatic
𝛼-Toc concentration found at 24 h. In addition, the hepatic
GSH concentration in ANIT-treated rats with administration
of BPEE (50 or 100mg/kg) was not different from that in
untreated control rats. The similarly administered VE had
no effect on the increased hepatic GSH and ascorbic acid
concentrations found at 24 h after ANIT treatment, although
the administered VE caused a marked increase in the hepatic
𝛼-Toc concentration, as reported previously [37]. It has been
suggested that hepatic GSH plays a causal or permissive
role in ANIT-induced liver damage with cholestasis in rats
through formation of a reversible GSH conjugate of ANIT
in the liver cells and transport of the GSH conjugate of
ANIT into the bile, where it dissociates to free ANIT and
GSH [21]. Jean et al. [56] have reported that increases in bile
GSH and ANIT concentrations occur before an increase in
hepatic GSH concentration in rats orally treated with ANIT
(100mg/kg). Therefore, it seems unlikely that the reduction
of increased hepatic GSH concentration found at 24 h after
ANIT treatment in rats by BPEE administered at 12 h affects
the formation of a reversible GSH conjugate of ANIT in the
liver cells.We have observed that oral administration of BPEE
(25, 50, or 100mg/kg) to ANIT-treated rats increases the
concentration of nonprotein-SH including GSH in the serum
in a dose-dependent manner (unpublished data). Therefore,
there is a possibility that BPEE administered to ANIT-treated
rats enhances the secretion of GSH from the liver tissue into
the bloodstream, resulting in a reduction of the increased
GSH concentration in the liver tissue.
The ethanol extract of Brazilian propolis is known to exert
anti-inflammatory action by inhibiting neutrophil infiltration
and the generation of ROS in activated neutrophils [29–
31]. VE is known to function as an anti-inflammatory agent
through inhibition of the generation of ROS in activated
neutrophils and neutrophil infiltration [33–35]. It has been
suggested that infiltrated neutrophils in the liver tissue of rats
treated with ANIT play a critical role in the development
of ANIT-induced liver injury with cholestasis [21, 22]. We
have shown that neutrophil infiltration into the liver tissue
of rats treated once with ANIT (75mg/kg, i.p.) increases at
12 h after the treatment, that is, before the appearance of liver
damage with cholestasis and further increases at 24 h [22, 37].
In the present study, a single oral administration of BPEE
(50mg/kg) to ANIT-treated rats at 12 h after the treatment
caused a significant attenuation of the increase in hepatic
MPO activity, an index of tissue neutrophil infiltration [47],
found at 24 h, although the similarly administered BPEE
(25 or 100mg/kg) had no significant effect on the increase
in hepatic MPO activity. The similarly administered VE
(250mg/kg) exerted a significant attenuating effect on the
increase in hepatic MPO activity, as reported previously [37],
although the administered VE was more effective than BPEE
administered at a dose of 50mg/kg. These results were well
consistent with the above-described histological observation
of liver cells. Thus, orally administered BPEE (50mg/kg) was
found to inhibit neutrophil infiltration into the liver tissue
of ANIT-treated rats like the case of orally administered VE.
It has been shown that activated neutrophils mediate lipid
peroxidation through the production of ROS via NADPH
oxidase in the cells [55]. It has also been shown that MPO
mediates lipid peroxidation in the presence of hydrogen per-
oxide and halide ions [57]. Accordingly, these findings allow
us to indicate that orally administered BPEE protects against
oxidative damage associated with excessive ROS generations
via infiltrated neutrophils in the liver tissue of rats treated
with ANIT possibly through its antiinflammatory action as
in the case of orally administered VE. We have observed that
BPEE in concentrations of a few 𝜇g/mL causes a strong inhi-
bition of the activity of authentic MPO isolated from human
neutrophils (unpublished data).Therefore, it seems likely that
orally administered BPEE contributes to its protective effect
against oxidative damage caused by infiltrated neutrophils
in the liver of ANIT-treated rats through inhibition of the
activity of MPO in the infiltrated neutrophils.
As to the above-described decrease in hepatic SOD
activity in ANIT-treated rats, it has been reported that the
decrease in SOD activity in the liver of rats treated once with
ANIT (75mg/kg, i.p.) is due to a decrease in the activity of
Cu, Zn-SOD present in the cytosol of liver cells [24]. Cu,Zn-
SOD is known to be inactivated by H
2
O
2
in vitro [58, 59]. It
is known that the ethanol extract of Brazilian green propolis
and several compounds present in the extract can scavenge
H
2
O
2
in vitro [28]. As described above, it was observed that
BPEE (50mg/kg) administered to ANIT-treated rats inhib-
ited infiltration of neutrophils to enable to produce H
2
O
2
via
activated NADPH oxidase into the liver tissue. Therefore, it
can be thought that BPEE (50mg/kg) orally administered to
ANIT-treated rats attenuates the reduction of SOD activity
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in the liver tissue by inhibiting neutrophil infiltration into
the tissue and/or by scavenging H
2
O
2
produced by infiltrated
neutrophils in the tissue.
Artepillin C was present as a main constituent in BPEE
used in the present study. It has been reported that artepillin
C exerts antioxidant action by scavenging ROS and by
inhibiting lipid peroxidation [28, 60–62]. Therefore, it is
suggested that the attenuating effect of administered BPEE on
increased LPO concentration and decreased SOD activity in
the liver of rats treated with ANIT could be mainly due to the
antioxidant action of artepillin C present in the extract.
As to the main reason why BPEE administered at a dose
of 100mg/kg was less effective in protecting ANIT-induced
liver damage with cholestasis than BPEE administered at a
dose of 50mg/kg, the following matters could be consid-
ered: BPEE (100mg/kg) administered to ANIT-treated rats
reduced hepatic catalase activity and was less effective in
inhibiting neutrophil infiltration into the liver tissue than
BPEE (50mg/kg) administered to the treated rats.
In conclusion, the results of the present study indicate
that a single oral administration of BPEE to rats treated once
with ANIT before the onset of apparent liver damage with
cholestasis protects against liver damage with cholestasis,
although this protective effect of BPEE diminishes at its high
dose. The present results also suggest that the protective
effect of BPEE against ANIT-induced liver damage with
cholestasis could be due to the antioxidant, antiinflammatory,
antihyperlipemic, and antihypertrophic actions of the extract.
The orally administered BPEE (50mg/kg) was found to
be more effective in protecting against ANIT-induced liver
damage with cholestasis than the similarly administered VE
(250mg/kg). However, further investigation is needed to
clarify the exact mechanism underlining the protective effect
of BPEE against liver damage with cholestasis in rats treated
with ANIT.
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